Price range: $84.99 through $114.99

Tirzepatide is an advanced synthetic peptide engineered as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This 39-amino acid compound has been widely examined in scientific literature for its role in metabolic signaling and regulatory pathways.

Description

Tirzepatide’s dual-receptor activity offers a unique mechanism that has been explored in controlled laboratory environments, particularly in studies focused on glucose homeostasis, energy balance, and metabolic function.

Key Features

  • High-purity research-grade peptide
  • Dual agonist targeting GIP and GLP-1 receptors
  • 39-amino acid synthetic structure
  • Lyophilized powder formulation
  • Supported by peer-reviewed scientific research
  • Third-party tested for purity and verification

Research Applications
Utilized in laboratory research investigating metabolic pathways, glucose regulation, and energy homeostasis.

Storage & Handling
Store at -20°C (lyophilized). After reconstitution, store at 2–8°C. Avoid repeated freeze-thaw cycles and protect from light.

Important Notice
This product is intended strictly for laboratory research and in vitro use. Not for human consumption, clinical application, diagnostic use, or therapeutic purposes. This product is not intended to diagnose, treat, cure, or prevent any disease. Handling should be performed only by qualified professionals in appropriate research settings.

Additional information

Sizes

10MG, 15MG, 20MG, 30MG

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide – Research Peptide”

Your email address will not be published. Required fields are marked *

Research Use Only

This website offers products intended strictly for laboratory and scientific research purposes only.

These products are not for human or animal consumption and are not medical products.

By entering, you confirm that you are 18 years or older and accessing this site for legitimate research purposes only.